Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
67
VONOY Quote, Financials, Valuation and Earnings
Last price:
$15.24
Seasonality move
:
-5.64%
Day range:
$15.02 - $15.37
52-week range:
$12.84 - $18.73
Dividend yield:
6.23%
P/E ratio:
--
P/S ratio:
4.51x
P/B ratio:
0.55x
Volume:
71K
Avg. volume:
47.8K
1-year change:
-0.39%
Market cap:
$17.5B
Revenue:
--
EPS (TTM):
--
| Period Ending | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.7B | $3.2B | $3.3B | $3.6B | |
| Revenue Growth (YoY) | 6.78% | 10.77% | 18.07% | 1.9% | 10.3% | |
| Cost of Revenues | $820M | $813.5M | $1.1B | $1.1B | $1.2B | |
| Gross Profit | $1.6B | $1.9B | $2.1B | $2.2B | $2.4B | |
| Gross Profit Margin | 66.47% | 69.97% | 64.75% | 66.57% | 66% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $135M | $127.2M | $164.8M | $148.6M | $143.6M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $594.6M | $705.7M | $1.7B | $3.3B | $978.8M | |
| Operating Income | $1B | $1.2B | $334.6M | -$1.1B | $1.4B | |
| Net Interest Expenses | $500.9M | $370.1M | $456.9M | $460.7M | $454.6M | |
| EBT. Incl. Unusual Items | $4.3B | $4.5B | $4.6B | $3.5B | $5.7B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.5B | $1.6B | $1.7B | $2.1B | $1.9B | |
| Net Income to Company | $2.8B | $2.9B | $2.8B | $1.4B | $3.8B | |
| Minority Interest in Earnings | -$190.6M | -$131.6M | -$113.7M | -$120.1M | -$81.7M | |
| Net Income to Common Excl Extra Items | $2.6B | $2.8B | $2.7B | $1.3B | $3.7B | |
| Basic EPS (Cont. Ops) | $2.73 | $2.87 | $2.65 | $1.20 | $3.35 | |
| Diluted EPS (Cont. Ops) | $2.73 | $2.87 | $2.65 | $1.20 | $3.35 | |
| Weighted Average Basic Share | $932M | $952.9M | $1B | $1.1B | $1.1B | |
| Weighted Average Diluted Share | $932M | $952.9M | $1B | $1.1B | $1.1B | |
| EBITDA | $4.8B | $5.3B | $5.9B | $6.4B | $6.3B | |
| EBIT | $4.8B | $4.9B | $5B | $4B | $6.2B | |
| Revenue (Reported) | $2.4B | $2.7B | $3.2B | $3.3B | $3.6B | |
| Operating Income (Reported) | $1B | $1.2B | $334.6M | -$1.1B | $1.4B | |
| Operating Income (Adjusted) | $4.8B | $4.9B | $5B | $4B | $6.2B | |
| Period Ending | 2017-09-30 | 2018-09-30 | 2019-09-30 | 2020-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $700.1M | $827.4M | $802.5M | $917.2M | $953.9M | |
| Revenue Growth (YoY) | 14.05% | 18.19% | -3.02% | 14.29% | 4% | |
| Cost of Revenues | $199.9M | $274.1M | $266.2M | $301.1M | $373.5M | |
| Gross Profit | $500.2M | $553.4M | $536.3M | $616M | $580.3M | |
| Gross Profit Margin | 71.45% | 66.88% | 66.83% | 67.17% | 60.84% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $182.9M | $235M | $419M | $202.4M | $147.3M | |
| Operating Income | $317.3M | $318.4M | $117.3M | $413.6M | $433.1M | |
| Net Interest Expenses | $81.7M | $116.9M | $134.1M | $122.8M | $168.4M | |
| EBT. Incl. Unusual Items | $254.4M | $326.9M | $114.6M | $455.7M | $2.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $89.1M | $95.5M | $183.5M | $135.9M | $651.9M | |
| Net Income to Company | $245.5M | $193.9M | -$70.3M | $430M | $1.3B | |
| Minority Interest in Earnings | -$10.1M | -$13.6M | -$1.9M | -$6.8M | -$6.1M | |
| Net Income to Common Excl Extra Items | $155.2M | $217.8M | -$70.7M | $313M | $1.4B | |
| Basic EPS (Cont. Ops) | $0.15 | $0.22 | -$0.07 | $0.27 | $1.20 | |
| Diluted EPS (Cont. Ops) | $0.15 | $0.22 | -$0.07 | $0.27 | $1.20 | |
| Weighted Average Basic Share | $956.9M | $945.8M | $1.1B | $1.1B | $1.2B | |
| Weighted Average Diluted Share | $956.9M | $945.8M | $1.1B | $1.1B | $1.2B | |
| EBITDA | $348.6M | $461.2M | $487.9M | $595.2M | $2.2B | |
| EBIT | $339.1M | $444.3M | $241.1M | $566.9M | $2.2B | |
| Revenue (Reported) | $700.1M | $827.4M | $802.5M | $917.2M | $953.9M | |
| Operating Income (Reported) | $317.3M | $318.4M | $117.3M | $413.6M | $433.1M | |
| Operating Income (Adjusted) | $339.1M | $444.3M | $241.1M | $566.9M | $2.2B | |
| Period Ending | 2017-09-30 | 2018-09-30 | 2019-09-30 | 2020-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6B | $3.1B | $3.2B | $3.5B | $3.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $792.4M | $1B | $1.1B | $1.1B | $1.4B | |
| Gross Profit | $1.8B | $2.1B | $2.1B | $2.3B | $2.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $672.9M | $858.4M | $4B | $989M | $1.3B | |
| Operating Income | $1.1B | $1.2B | -$1.9B | $1.4B | $1.1B | |
| Net Interest Expenses | $338.8M | $478.2M | $515.3M | $413M | $576.1M | |
| EBT. Incl. Unusual Items | $5.7B | $5.1B | $3.1B | $5.5B | $9.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2B | $1.8B | $1.9B | $2B | $3.2B | |
| Net Income to Company | $3.9B | $3.1B | $1.3B | $3.6B | $6.2B | |
| Minority Interest in Earnings | -$179M | -$123.8M | -$64.1M | -$160.6M | -$101.1M | |
| Net Income to Common Excl Extra Items | $3.6B | $3.1B | $1.2B | $3.3B | $6.3B | |
| Basic EPS (Cont. Ops) | $3.77 | $3.18 | $1.09 | $3.02 | $5.47 | |
| Diluted EPS (Cont. Ops) | $3.77 | $3.18 | $1.09 | $3.02 | $5.47 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $6.1B | $6B | $6.8B | $6.1B | $10.4B | |
| EBIT | $6.1B | $5.5B | $3.6B | $6B | $10.1B | |
| Revenue (Reported) | $2.6B | $3.1B | $3.2B | $3.5B | $3.9B | |
| Operating Income (Reported) | $1.1B | $1.2B | -$1.9B | $1.4B | $1.1B | |
| Operating Income (Adjusted) | $6.1B | $5.5B | $3.6B | $6B | $10.1B | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.6B | $250.7M | $561.1M | $560.9M | $557.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $173.8M | $281.8M | $563.8M | $230.4M | $330.7M | |
| Inventory | $5.3M | $7.4M | $361.4M | $411.2M | $712.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $85M | $96.7M | $112.1M | $137.9M | $124.5M | |
| Total Current Assets | $2.2B | $955.8M | $2B | $1.6B | $2.2B | |
| Property Plant And Equipment | $122.3M | $213.1M | $286.4M | $401.7M | $476.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $2.9B | $3.1B | $3.3B | -- | $1.8B | |
| Other Intangibles | $25.6M | $28.3M | $115.3M | -- | $143.9M | |
| Other Long-Term Assets | $6.6M | $8.3M | $7.2M | $55.4M | $151.8M | |
| Total Assets | $34.4B | $45B | $56.5B | $63.3B | $76.8B | |
| Accounts Payable | $146.7M | $156.8M | $273.5M | $245.4M | $282.3M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $4.8M | $14.8M | $125.1M | $163.7M | $179.5M | |
| Other Current Liabilities | $185.3M | $219.2M | $821M | $408M | $391.6M | |
| Total Current Liabilities | $2.5B | $2.7B | $4.7B | $4B | $3.6B | |
| Long-Term Debt | $12.3B | $14.9B | $19.9B | -- | $27.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $19.7B | $25B | $34B | $39.6B | $46.2B | |
| Common Stock | $492.6M | $582M | $592.7M | $607.5M | $696M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $14.2B | $19.3B | $21.6B | $22.8B | $29.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $443M | $730.4M | $894.9M | $911.7M | $844.1M | |
| Total Equity | $14.7B | $20B | $22.5B | $23.7B | $30.5B | |
| Total Liabilities and Equity | $34.4B | $45B | $56.5B | $63.3B | $76.8B | |
| Cash and Short Terms | $1.6B | $250.7M | $561.1M | $560.9M | $557.7M | |
| Total Debt | $14.1B | $16.8B | $22.9B | $2.6B | $29.5B | |
| Period Ending | 2017-09-30 | 2018-09-30 | 2019-09-30 | 2020-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $400.3M | $589.5M | $1.3B | $2B | $2.5B | |
| Short Term Investments | -- | $6.5M | $6.3M | $6.2M | $2.3B | |
| Accounts Receivable, Net | $260.4M | $504.9M | $290.4M | $332.1M | $531.6M | |
| Inventory | $7.1M | $358.6M | $350.2M | $571.6M | $619.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $175.3M | $192.5M | $184.9M | $174.7M | $292.1M | |
| Total Current Assets | $992.3M | $1.8B | $2.3B | $3.2B | $10B | |
| Property Plant And Equipment | $171.2M | $276.4M | $368.5M | $429.6M | $662.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $25.8M | $21.4M | $18.1M | $122.2M | $173.8M | |
| Total Assets | $41.7B | $55.2B | $55.7B | $71.2B | $126B | |
| Accounts Payable | $154.2M | $246.8M | $243.5M | $247.5M | $416.8M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $5.8M | $127.6M | $158.3M | $162M | $181.1M | |
| Other Current Liabilities | $181.7M | $301.3M | $285.2M | $264M | $14.2B | |
| Total Current Liabilities | $3.3B | $3.9B | $3.3B | $3.2B | $25.6B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $23.5B | $33B | $34B | $43.7B | $92.7B | |
| Common Stock | $571.5M | $602M | $593.3M | $664.4M | $667.3M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $778.2M | $1.2B | $732.1M | $954.7M | $1.4B | |
| Total Equity | $18.2B | $22.2B | $21.7B | $27.5B | $33.3B | |
| Total Liabilities and Equity | $41.7B | $55.2B | $55.7B | $71.2B | $126B | |
| Cash and Short Terms | $400.3M | $596M | $1.3B | $2B | $4.8B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.8B | $2.9B | $2.8B | $1.4B | $3.8B | |
| Depreciation & Amoritzation | $29.9M | $421.5M | $871.3M | $2.4B | $105.4M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $917.4M | $1.1B | $1.3B | $1.7B | $1.6B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | $332K | -$1.6B | -$4B | -$1.9B | -$377.2M | |
| Cash From Investing | $460.9M | -$1.5B | -$4.6B | -$2.8B | -$2B | |
| Dividends Paid (Ex Special Dividend) | -- | -$314.7M | -$473.6M | -$467.6M | -$594.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.9B | $3.3B | $6B | $6B | $4.8B | |
| Long-Term Debt Repaid | -$4.7B | -$3.7B | -$2.2B | -$4.1B | -$4.3B | |
| Repurchase of Common Stock | -$44.3M | -$45.3M | -$47.2M | -$44.8M | -$45.7M | |
| Other Financing Activities | -$815.7M | -$209.5M | -$391.2M | -$691.4M | -$36.5M | |
| Cash From Financing | -$3.1B | -$985.8M | $3.6B | $1B | $459.8M | |
| Beginning Cash (CF) | $3.4B | $1.7B | $314.3M | $613.1M | $571.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.7B | -$1.4B | $332.4M | -$52.6M | $117.9M | |
| Ending Cash (CF) | $1.7B | $301.5M | $646.7M | $560.5M | $700.4M | |
| Levered Free Cash Flow | $917.4M | $1.1B | $1.3B | $1.7B | $1.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $430M | $1.3B | -- | -- | -- | |
| Depreciation & Amoritzation | $31.2M | $19.2M | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $512.8M | $375.4M | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$128.4M | -$7.7B | -- | -- | -- | |
| Cash From Investing | -$527.6M | -$5.7B | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | $2.1M | $594.2M | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $4.5B | $14.5B | -- | -- | -- | |
| Long-Term Debt Repaid | -$3.1B | -$2.6B | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.6B | -$7.2B | -- | -- | -- | |
| Cash From Financing | $940.7M | $5.2B | -- | -- | -- | |
| Beginning Cash (CF) | $1B | $2.7B | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -$1.5M | -$1.2M | -- | -- | -- | |
| Additions / Reductions | $925.9M | -$135.1M | -- | -- | -- | |
| Ending Cash (CF) | $2B | $2.6B | -- | -- | -- | |
| Levered Free Cash Flow | $512.8M | $375.4M | -- | -- | -- | |
| Period Ending | 2017-09-30 | 2018-09-30 | 2019-09-30 | 2020-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.9B | $3.1B | $1.3B | $3.6B | $6.2B | |
| Depreciation & Amoritzation | $38.6M | $438.4M | $3.2B | $114M | $329.4M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.1B | $1.2B | $1.6B | $1.7B | $1.7B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$1.7B | -$3.9B | -$59M | -$2.2B | -$7.8B | |
| Cash From Investing | -$1.3B | -$4.6B | -$637.5M | -$3.8B | -$10.7B | |
| Dividends Paid (Ex Special Dividend) | -$319.9M | $5.2M | -$473.6M | -$467.6M | -$594.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.1B | $6.5B | $4.5B | $6.8B | $14.8B | |
| Long-Term Debt Repaid | -$3.2B | -$2.7B | -$3.9B | -$3.9B | -$3.7B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$123.7M | -$952.3M | -$629.8M | -$266.5M | -$17.7M | |
| Cash From Financing | -$704.1M | $3.6B | -$209.4M | $2.8B | $9.6B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$925.5M | $248.8M | $730M | $689.3M | $540.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.1B | $1.2B | $1.6B | $1.7B | $1.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.2B | $4.6B | -- | -- | -- | |
| Depreciation & Amoritzation | $77.6M | $301.6M | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.2B | $1.2B | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$264.3M | -$7.7B | -- | -- | -- | |
| Cash From Investing | -$1.4B | -$10.2B | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$0 | $0 | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $4.5B | $14.5B | -- | -- | -- | |
| Long-Term Debt Repaid | -$3.1B | -$2.6B | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$616.7M | -$597.9M | -- | -- | -- | |
| Cash From Financing | $1.6B | $10.8B | -- | -- | -- | |
| Beginning Cash (CF) | $2.1B | $6B | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -$1.5M | -$1.9M | -- | -- | -- | |
| Additions / Reductions | $1.4B | $1.8B | -- | -- | -- | |
| Ending Cash (CF) | $3.5B | $7.9B | -- | -- | -- | |
| Levered Free Cash Flow | $1.2B | $1.2B | -- | -- | -- | |
Get VONOY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
VONOY
Sector
P/E ratio
--
21.43x
PEG ratio
0.03x
0.19x
P/B ratio
0.55x
0.80x
Price / LTM sales
4.51x
3.51x
Growth Metrics
VONOY
Sector
Revenue growth
--
3.19%
Earnings growth
--
--
Revenue (5-year growth)
--
3.36%
Earnings forecast
--
$0.16
Profitability
VONOY
Sector
Profitability FY 2024
--
$211.9M
Return on invested capital
--
1.17%
Return on assets
--
1.05%
Return on equity
--
2.3%
Earnings Date
Last Earnings Date
Aug
2
Next Earnings Date
Dec
23
Estimated Next Earnings Date
Mar
24
Balance Sheet
VONOY
Sector
Total cash
--
$76.4M
Short term investments
--
$21.6M
Total assets
--
$3.5B
Long term debt
--
$1.2B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
